241 related articles for article (PubMed ID: 12544552)
1. Patient and community preferences for outcomes in prostate cancer: implications for clinical policy.
Krahn M; Ritvo P; Irvine J; Tomlinson G; Bremner KE; Bezjak A; Trachtenberg J; Naglie G
Med Care; 2003 Jan; 41(1):153-64. PubMed ID: 12544552
[TBL] [Abstract][Full Text] [Related]
2. Predicting utility scores for prostate cancer: mapping the Prostate Cancer Index to the Patient-Oriented Prostate Utility Scale (PORPUS).
Bremner KE; Mitsakakis N; Wilson L; Krahn MD
Prostate Cancer Prostatic Dis; 2014 Mar; 17(1):47-56. PubMed ID: 24126796
[TBL] [Abstract][Full Text] [Related]
3. A reference set of health utilities for long-term survivors of prostate cancer: population-based data from Ontario, Canada.
Krahn MD; Bremner KE; Alibhai SM; Ni A; Tomlinson G; Laporte A; Naglie G
Qual Life Res; 2013 Dec; 22(10):2951-62. PubMed ID: 23564620
[TBL] [Abstract][Full Text] [Related]
4. Measuring prostate-specific quality of life in prostate cancer patients scheduled for radiotherapy or radical prostatectomy and reference men in Germany and Canada using the Patient Oriented Prostate Utility Scale-Psychometric (PORPUS-P).
Waldmann A; Rohde V; Bremner K; Krahn M; Kuechler T; Katalinic A
BMC Cancer; 2009 Aug; 9():295. PubMed ID: 19698163
[TBL] [Abstract][Full Text] [Related]
5. Estimating preferences for treatments in patients with localized prostate cancer.
Ávila M; Becerra V; Guedea F; Suárez JF; Fernandez P; Macías V; Mariño A; Hervás A; Herruzo I; Ortiz MJ; Ponce de León J; Sancho G; Cunillera O; Pardo Y; Cots F; Ferrer M;
Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):277-87. PubMed ID: 25491504
[TBL] [Abstract][Full Text] [Related]
6. Preference-based measurement of health-related quality of life (HRQL) in children with chronic musculoskeletal disorders (MSKDs).
Brunner HI; Maker D; Grundland B; Young NL; Blanchette V; Stain AM; Feldman BM
Med Decis Making; 2003; 23(4):314-22. PubMed ID: 12926581
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a utility weighting function for the patient-oriented prostate utility scale (PORPUS).
Tomlinson G; Bremner KE; Ritvo P; Naglie G; Krahn MD
Med Decis Making; 2012; 32(1):11-30. PubMed ID: 21653804
[TBL] [Abstract][Full Text] [Related]
8. Quality of life and treatment outcomes: prostate carcinoma patients' perspectives after prostatectomy or radiation therapy.
Shrader-Bogen CL; Kjellberg JL; McPherson CP; Murray CL
Cancer; 1997 May; 79(10):1977-86. PubMed ID: 9149026
[TBL] [Abstract][Full Text] [Related]
9. Long-term morbidity and quality of life in patients with localized prostate cancer undergoing definitive radiotherapy or radical prostatectomy.
Lilleby W; Fosså SD; Waehre HR; Olsen DR
Int J Radiat Oncol Biol Phys; 1999 Mar; 43(4):735-43. PubMed ID: 10098428
[TBL] [Abstract][Full Text] [Related]
10. Adaptation and validation of the Spanish version of the Patient-Oriented Prostate Utility Scale (PORPUS).
Avila M; Pardo Y; Castells M; Ferrer F; Boladeras A; Pera J; Prada PJ; Guix B; de Paula B; Hernandez H; Pont A; Alonso J; Garin O; Bremner K; Krahn M; Ferrer M;
Qual Life Res; 2014 Nov; 23(9):2481-7. PubMed ID: 24789667
[TBL] [Abstract][Full Text] [Related]
11. Do visual analogue scale (VAS) derived standard gamble (SG) utilities agree with Health Utilities Index utilities? A comparison of patient and community preferences for health status in rheumatoid arthritis patients.
Rashidi AA; Anis AH; Marra CA
Health Qual Life Outcomes; 2006 Apr; 4():25. PubMed ID: 16626489
[TBL] [Abstract][Full Text] [Related]
12. Utilities for prostate cancer health states in men aged 60 and older.
Stewart ST; Lenert L; Bhatnagar V; Kaplan RM
Med Care; 2005 Apr; 43(4):347-55. PubMed ID: 15778638
[TBL] [Abstract][Full Text] [Related]
13. Patient preferences for outcomes associated with surgical management of prostate cancer.
Smith DS; Krygiel J; Nease RF; Sumner W; Catalona WJ
J Urol; 2002 May; 167(5):2117-22. PubMed ID: 11956454
[TBL] [Abstract][Full Text] [Related]
14. Predictors of preferences and utilities in men treated with 3D-CRT for prostate cancer.
Bruner DW; Hanlon A; Mazzoni S; Raysor S; Konski A; Hanks G; Pollack A
Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):34-42. PubMed ID: 14697418
[TBL] [Abstract][Full Text] [Related]
15. Comparative quality-of-life analysis after radical prostatectomy or external beam radiation for localized prostate cancer.
McCammon KA; Kolm P; Main B; Schellhammer PF
Urology; 1999 Sep; 54(3):509-16. PubMed ID: 10475363
[TBL] [Abstract][Full Text] [Related]
16. Stability of time trade-off utilities for health states associated with the treatment of prostate cancer.
Saigal CS; Gornbein J; Reid K; Litwin MS
Qual Life Res; 2002 Aug; 11(5):405-14. PubMed ID: 12113388
[TBL] [Abstract][Full Text] [Related]
17. Quality of life impact of treatments for localized prostate cancer: cohort study with a 5 year follow-up.
Ferrer M; Guedea F; Suárez JF; de Paula B; Macías V; Mariño A; Hervás A; Herruzo I; Ortiz MJ; Ponce de León J; Sancho G; Boladeras A; Ayala A; Craven-Bratle J; Ávila M; Cunillera O; Pardo Y; Alonso J; Aguiló F;
Radiother Oncol; 2013 Aug; 108(2):306-13. PubMed ID: 23849168
[TBL] [Abstract][Full Text] [Related]
18. Population-based study of long-term functional outcomes after prostate cancer treatment.
Carlsson S; Drevin L; Loeb S; Widmark A; Lissbrant IF; Robinson D; Johansson E; Stattin P; Fransson P
BJU Int; 2016 Jun; 117(6B):E36-45. PubMed ID: 25959859
[TBL] [Abstract][Full Text] [Related]
19. Health-related quality of life after radical retropubic prostatectomy and permanent prostate brachytherapy: a 3-year follow-up study.
Hashine K; Yuasa A; Shinomori K; Ninomiya I; Kataoka M; Yamashita N
Int J Urol; 2011 Dec; 18(12):813-9. PubMed ID: 21995507
[TBL] [Abstract][Full Text] [Related]
20. Preferences for Prostate Cancer Outcomes: A Comparison of the Patient Perspective, the General Population Perspective, and a Population at Risk for Prostate Cancer.
Gries KS; Regier DA; Ramsey SD; Patrick DL
Value Health; 2016; 19(2):218-25. PubMed ID: 27021756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
